BRIEF

on CEGEDIM (EPA:CGM)

Integration of BIOrecos data into Senior+ by Claude Bernard AI

Stock price chart of CEGEDIM (EPA:CGM) showing fluctuations.

Claude Bernard has announced the integration of BIOrecos data into its recently launched Senior+ artificial intelligence assistant. This integration aims to facilitate consultations for general practitioners, particularly with elderly patients.

Senior+ is designed to assist physicians in complex consultations by directly integrating relevant biological data. The partnership with BIOrecos, a recognized source in medical biology, enriches the assistant's database with reliable and up-to-date biological information.

The main objective is to streamline the care pathway and increase the safety of prescriptions through improved access to validated information. This reduces manual searches and improves the quality of care provided to elderly patients.

R. H.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all CEGEDIM news